Delta Gold Technologies plc has enhanced its Strategic Advisory Panel by appointing Professor Dr Harry Ruda of the University of Toronto and Professor Ken Knappenberger from The Pennsylvania State University, reinforcing the quantum computing firm’s scientific leadership. These appointments come after Dr Thomas P Davis joined in May 2026 and coincide with the issuance of 336,000 new ordinary shares at 15p each due to investor warrant exercises. These developments bolster Delta’s capabilities in advancing intellectual property across quantum materials, computing, sensing, and communication technologies.
Key Points
- Delta Gold Technologies plc (Aquis: DGQ / OTCQB: DGQTF / FRA: O2J) has added two leading academic researchers to its Strategic Advisory Panel
- Professor Dr Harry Ruda and Professor Ken Knappenberger lead Delta-funded research at the University of Toronto and The Pennsylvania State University respectively
- The company issued 336,000 new ordinary shares at 15p each following warrant exercises, with Aquis admission expected around 23 July 2026
- Post-issuance, Delta’s total issued share capital will be 65,851,791 ordinary shares of 0.2p each
Focus on Quantum Materials and Collaborative Academic Research
Delta Gold Technologies specializes in developing intellectual property centered on nano-scale gold and advanced materials for quantum information science. Its strategic goal is to engineer gold at the nanoscale to create unique, protectable quantum technology platforms. The company’s research targets quantum computing, sensing, and communication, positioning it prominently within the fast-growing quantum information technology sector.
Delta operates through sponsored research partnerships with premier institutions such as The Pennsylvania State University and the University of Toronto. These collaborations grant Delta intellectual property rights from research programs, including patents filed by both universities. This model enables access to cutting-edge research while maintaining operational efficiency and building a robust patent portfolio through licensing and strategic alliances. CEO R. Michael Jones emphasized the company’s commitment to assessing progress, exploring commercial pathways, and expanding its intellectual property across quantum computing, sensing, and communication. The geographic spread of research activities across Canadian and U.S. institutions provides complementary expertise and potential regulatory benefits in key markets.
Enhancing Governance with Strategic Advisory Panel Expansion
Delta’s Strategic Advisory Panel supports the Board and management in prioritizing and executing scientific and research investments. Established in May 2026 with Dr Thomas P Davis—co-founder and CEO of Oxford Sigma—the panel benefits from his materials science expertise and commercial experience bridging research and market applications.
The panel’s responsibilities include identifying high-value research projects, overseeing scientific programs, advising on intellectual property strategy, originating opportunities, and fostering strategic partnerships. The addition of Professors Ruda and Knappenberger brings senior academic leadership aligned with Delta’s research portfolio, strengthening the connection between university collaborations and commercialization efforts. This advisory framework formalizes expert input into Delta’s strategic decision-making processes.
Professor Dr Harry Ruda: Expert in Quantum Nanostructures and Nanotechnology
Professor Harry E. Ruda, with a B.Sc. from Imperial College and a PhD from MIT, has extensive expertise in quantum nanostructures, nanoelectronics, and nanophotonics. An IBM Postdoctoral Fellow, he conducted foundational research on electron transport in quantum nanostructures and contributed to semiconductor blue laser development at 3M Corporation.
Since 1989, Professor Ruda has served at the University of Toronto, directing its Centre for Nanotechnology since 1997. He has authored over 300 peer-reviewed papers, four books, and holds 14 patents. His research on fabricating and modeling quantum functional nanostructures for nanoelectronics and nanophotonics aligns closely with Delta’s nanoscale gold engineering strategy. His advisory role integrates deep scientific expertise into Delta’s strategic and intellectual property development efforts.
Professor Ken Knappenberger: Leader in Quantum Materials and Spectroscopy
Professor Kenneth L. Knappenberger Jr., Head of Chemistry at The Pennsylvania State University, focuses on optical, electronic, and spin properties of structurally precise nanomaterials, especially gold nanoclusters. His PhD from Penn State and postdoctoral work at UC Berkeley underpin his expertise in advanced materials characterization.
Previously at Florida State University, he led the magneto-optics program at the National High Magnetic Field Laboratory. Since joining Penn State in 2017, he has published over 100 papers and delivered 300+ lectures on molecular coherence and spin properties. His accolades include the Coblentz Award, Young Investigator Award from the Inter-American Photochemical Society, NSF and DoD CAREER awards, and fellowships in the AAAS and Optica. His specialized knowledge in gold nanoclusters supports Delta’s quantum materials development strategy.
Warrant Exercise Drives Share Capital Increase
Delta issued 336,000 new ordinary shares at 15p each following the exercise of warrants linked to its December 2025 Aquis admission. This issuance reflects investor confidence and provides a capital raise aligned with the company’s listing process. The new shares hold equal rights with existing shares traded on Aquis.
Admission of these shares to Aquis is expected around 23 July 2026, enhancing market liquidity. The warrant exercise mechanism offers non-dilutive funding by converting pre-existing rights rather than issuing discounted shares, underscoring investor support for Delta’s quantum materials technology focus.
Updated Share Capital and Voting Rights Structure
After admission, Delta’s issued share capital will total 65,851,791 ordinary shares of 0.2p each, representing full voting rights and serving as the basis for FCA Disclosure and Transparency Rules compliance. This structure aids shareholders and market participants in monitoring substantial holdings and regulatory notifications.
The 0.2p nominal share value is typical for technology firms, providing flexibility for future capital transactions. The 15p warrant exercise price establishes a valuation benchmark reflecting investor demand for participation in Delta’s quantum technology development.
Dr Thomas P Davis and Oxford Sigma’s Advanced Materials Expertise
Dr Thomas P Davis, appointed in May 2026, brings a unique blend of scientific and commercial expertise as co-founder and CEO of Oxford Sigma, operating in the UK and US advanced materials sectors. Holding a DPhil in Materials Science from Oxford University, Dr Davis bridges academic research and market commercialization, aligning with Delta’s goal to convert quantum materials research into viable products.
Oxford Sigma’s multinational operations provide Dr Davis with valuable regulatory and commercialization experience relevant to quantum materials, which face export controls and security considerations. His advisory role ensures continuity between research, intellectual property development, and commercial opportunity identification. Together with Professors Ruda and Knappenberger, the panel combines expertise in quantum nanostructures, gold nanoclusters, and commercial materials development, supporting Delta’s integrated scientific and strategic approach.
Governance of Research Programs and Intellectual Property Growth
The Strategic Advisory Panel guides Delta’s scientific strategy and R&D allocation, focusing on translating research into defensible intellectual property and commercially relevant applications. Integrating principal investigators from sponsored research programs into strategic planning enhances research prioritization and patent development quality.
Professors Ruda and Knappenberger lead programs central to Delta’s investment thesis on nanoscale gold engineering for quantum technology platforms. The panel’s mandate includes intellectual property strategy and identifying patentable innovations, facilitating the conversion of academic research into commercial assets. Delta has secured IP rights from collaborations with Penn State and the University of Toronto, including patent filings. The panel’s involvement in IP strategy will influence patent scope, jurisdictions, and commercialization routes across Delta’s quantum materials, computing, sensing, and communication initiatives.
Quantum Information Science Market Dynamics and Technology Drivers
Delta operates in the rapidly advancing quantum information science sector, attracting significant global research funding and commercial interest from tech firms, governments, and investors. Quantum computing, sensing, and communication are complementary domains with applications in defense, telecom, finance, and research.
Utilizing nanoscale gold and structurally precise nanomaterials offers potential performance and cost advantages over other quantum platforms. Increased government funding in North America and Europe supports national quantum initiatives, research programs, and technology roadmaps. Delta’s collaborations with leading North American universities position it well within these ecosystems. The appointment of renowned researchers to the advisory panel may enhance access to funding, partnerships, and licensing opportunities. The sector’s emphasis on defensible IP through patents aligns with Delta’s governance prioritizing IP strategy and portfolio growth.
Competitive Positioning and Differentiation Strategy
Delta’s differentiation lies in its focus on nanoscale gold engineering and structurally precise nanomaterials for quantum technology, setting it apart from competitors working with superconducting qubits, trapped ions, photonics, or neutral atoms. This specialization creates unique IP development and licensing prospects for gold-based quantum solutions.
Research partnerships with Penn State and the University of Toronto provide complementary expertise in quantum nanostructure fabrication and gold nanocluster characterization. Delta’s listings on Aquis, OTCQB (DGQTF), and Frankfurt (O2J) grant access to diverse investor bases and reflect the global nature of quantum technology development and licensing potential.
Positioned as an IP development company rather than a manufacturer, Delta pursues flexible commercial pathways including licensing, research funding collaborations, and potential acquisition by larger quantum technology firms. The advisory panel appointments underscore Delta’s commitment to scientific rigor and expert oversight as it advances its intellectual property commercialization strategy.
This article is for informational purposes only and does not constitute investment advice. Details are based on publicly available company disclosures and regulatory filings. Investors should perform independent research, seek professional financial advice, and review all relevant company documents before making investment decisions. Past advisory appointments and research performance do not guarantee future commercial success or returns. Quantum technology development involves significant risks including technical challenges, commercialization hurdles, and competition from alternative platforms. Readers are advised to consult qualified financial advisers before investing in Delta Gold Technologies plc shares or warrants.